Clinical Trial Update: Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial comparing secukinumab with ustekinumab in adults with active psoriatic arthritis after TNFα-inhibitor failure has completed and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Cosentyx (secukinumab)
• Stelara (ustekinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2025-10-16